# Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer

> **NCT00595972** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 25 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** ECF-endostar

## Key facts

- **NCT ID:** NCT00595972
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595972, "Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00595972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*